Vaccibody.com | News
8
blog,paged,paged-6,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-16.6,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-5.5.5,vc_responsive

Vaccibody raises 875 000 € in new share issues. The Norwegian Radium Hospital Research Foundation and Sarsia Seed together invested € 760 000 and additional 9 investors added € 115 000 in the share issue held June 28th. “This successful share issue allows us to...

A report addressing solutions for strengthening the Norwegian biotechindustry was handed over to the Norwegian government May 20th. Vaccibody was the company being exemplified in the accompanying article in Dagens Næringsliv. Read the article here (Norwegian only)....

The European Life Science CEO forum, Zürich March 6-7 BIO Europe Spring, Amsterdam  March 19-21 Anglo Nordic Biotech Conference. London May 24. EPIC ,London May 31. 2012 BIO international convention, Boston June 18-21 ...

Vaccibody is the only Norwegian partner in the large EU-project, ADITEC. More information on the project is now launched at this site: http://www.aditecproject.eu/ ...